Combretastatin A4 disodium phosphate-induced myocardial injury.

about

A dose-escalation study of combretastatin A4-phosphate in healthy dogs.Histopathological and functional changes in a single-dose model of combretastatin A4 disodium phosphate-induced myocardial damage in rats

P2860

Q48268319-A64AAEE0-F02D-48BC-B8FA-31B7C5BC83B5 Q58596237-6D108D5E-35E0-445D-8B83-173E32953425

P2860

Combretastatin A4 disodium phosphate-induced myocardial injury.

Item

http://www.wikidata.org/entity/Q42398820

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combretastatin A4 disodium phosphate-induced myocardial injury.

@en

Combretastatin A4 disodium phosphate-induced myocardial injury.

@nl

type

Item

label

Combretastatin A4 disodium phosphate-induced myocardial injury.

@en

Combretastatin A4 disodium phosphate-induced myocardial injury.

@nl

prefLabel

Combretastatin A4 disodium phosphate-induced myocardial injury.

@en

Combretastatin A4 disodium phosphate-induced myocardial injury.

@nl

P1476

Combretastatin A4 disodium phosphate-induced myocardial injury.

@en

P2093

Chie Hata

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Yoshizawa

http://www.w3.org/2001/XMLSchema#string

Kazumi Uchida

http://www.w3.org/2001/XMLSchema#string

Kimiyuki Kaneko

http://www.w3.org/2001/XMLSchema#string

Masayoshi Kuwahara

http://www.w3.org/2001/XMLSchema#string

Minoru Ando

http://www.w3.org/2001/XMLSchema#string

Naoyuki Asakawa

http://www.w3.org/2001/XMLSchema#string

Ryota Tochinai

http://www.w3.org/2001/XMLSchema#string

Shoichi Kado

http://www.w3.org/2001/XMLSchema#string

Tomo Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

Microtubules in cardiac toxicity and disease.

Cardiovascular toxicity profiles of vascular-disrupting agents.

Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.

Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents.

Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles

The utility of the small rodent electrocardiogram in toxicology.

The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.

P304

163-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1293/TOX.2016-0012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27559241

http://www.w3.org/2001/XMLSchema#string

P932

4963615

http://www.w3.org/2001/XMLSchema#string

Combretastatin A4 disodium phosphate-induced myocardial injury.

about

P2860

P2860

Combretastatin A4 disodium phosphate-induced myocardial injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932